26 related articles for article (PubMed ID: 8964394)
21. Human colonic aspirates containing immunoglobulin A antibody to Clostridium difficile toxin A inhibit toxin A-receptor binding.
Kelly CP; Pothoulakis C; Orellana J; LaMont JT
Gastroenterology; 1992 Jan; 102(1):35-40. PubMed ID: 1309359
[TBL] [Abstract][Full Text] [Related]
22. Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc.
Krivan HC; Clark GF; Smith DF; Wilkins TD
Infect Immun; 1986 Sep; 53(3):573-81. PubMed ID: 3744552
[TBL] [Abstract][Full Text] [Related]
23. Ketotifen inhibits Clostridium difficile toxin A-induced enteritis in rat ileum.
Pothoulakis C; Karmeli F; Kelly CP; Eliakim R; Joshi MA; O'Keane CJ; Castagliuolo I; LaMont JT; Rachmilewitz D
Gastroenterology; 1993 Sep; 105(3):701-7. PubMed ID: 8395445
[TBL] [Abstract][Full Text] [Related]
24. A human antibody binds to alpha-galactose receptors and mimics the effects of Clostridium difficile toxin A in rat colon.
Pothoulakis C; Galili U; Castagliuolo I; Kelly CP; Nikulasson S; Dudeja PK; Brasitus TA; LaMont JT
Gastroenterology; 1996 Jun; 110(6):1704-12. PubMed ID: 8964394
[TBL] [Abstract][Full Text] [Related]
25. Microbes and microbial toxins: paradigms for microbial-mucosal interactions II. The integrated response of the intestine to Clostridium difficile toxins.
Pothoulakis C; Lamont JT
Am J Physiol Gastrointest Liver Physiol; 2001 Feb; 280(2):G178-83. PubMed ID: 11208538
[TBL] [Abstract][Full Text] [Related]
26.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
